ClinConnect ClinConnect Logo
Search / Trial NCT06741631

MyPEEPS LITE Trial

Launched by COLUMBIA UNIVERSITY · Dec 15, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

The MyPEEPS LITE Trial is a research study aimed at finding better ways to prevent HIV infections among young men who have sex with men and non-binary individuals assigned male at birth. The study will involve 2,500 participants aged 16 to 29 years and will compare a new mobile health program called MyPEEPS Mobile to standard care. The goal is to see if using this mobile program can help reduce new HIV infections in people who are at high risk.

To be eligible for the trial, participants must be between 16 and 29 years old, identify as male or non-binary, live in the U.S., and own a smartphone. They also need to have had anal sex with someone who has a penis in the past year and be HIV-negative or unaware of their status. Those who identify as transgender are not eligible for this study. Participants will receive guidance and support throughout the trial and will help researchers understand how community-based messages can improve HIV prevention efforts.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • Be between 16-29 years of age;
  • Sex assigned at birth is male and identify gender as male or non-binary;
  • Understand and read English;
  • Live within US and its territories;
  • Own or have access to a smartphone;
  • Self-report anal sex with someone who has a penis in the last 12 months; and
  • Be HIV-negative or status unknown
  • Exclusion Criteria:
  • Individuals who identify as transgender

About Columbia University

Columbia University, a prestigious Ivy League institution located in New York City, is a leading sponsor of clinical trials dedicated to advancing medical research and improving patient care. With a robust network of research facilities and a commitment to innovation, Columbia University collaborates with a diverse range of healthcare professionals and researchers to explore groundbreaking therapies and treatment methodologies. The university's clinical trials encompass various fields, including oncology, neurology, and public health, aiming to translate scientific discoveries into effective clinical applications. Columbia University is dedicated to maintaining the highest ethical standards and regulatory compliance, ensuring the safety and well-being of trial participants while contributing to the global body of medical knowledge.

Locations

New York, New York, United States

Chicago, Illinois, United States

Patients applied

LH

1 patients applied

Trial Officials

Rebecca Schnall, PhD, MPH

Principal Investigator

Columbia University

Robert Garofalo, MD, MPH

Principal Investigator

Ann & Robert H Lurie Children's Hospital of Chicago

Dustin Duncan, ScD

Principal Investigator

Columbia University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported